12 min

Maladies and mice. Pre-clinical vaccine development Vaccines - From Concept to Clinic with Oxford Sparks

    • Education

Approaches used to target particularly tricky diseases to treat, such as malaria, HIV, Flu and TB. Whilst many of the world’s major diseases can be targeted by vaccines there is a drastic need for new or improved vaccines against a number of the most deadly including HIV, malaria, Tuberculosis and Influenza. In this episode we discuss why these diseases and others have been particularly difficult to target by vaccination and the approaches currently being used in the development of vaccines targeting them. Featuring guests, Lynda Coughlan and Rachel Tanner. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

Approaches used to target particularly tricky diseases to treat, such as malaria, HIV, Flu and TB. Whilst many of the world’s major diseases can be targeted by vaccines there is a drastic need for new or improved vaccines against a number of the most deadly including HIV, malaria, Tuberculosis and Influenza. In this episode we discuss why these diseases and others have been particularly difficult to target by vaccination and the approaches currently being used in the development of vaccines targeting them. Featuring guests, Lynda Coughlan and Rachel Tanner. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

12 min

Top Podcasts In Education

Learning English Conversations
BBC Radio
Lessons for Life
Gaur Gopal Das
20 Minute Books
20 Minute Books
Rizwanani
rizwanani
All About Money
Nepali Money Guide
English Learning for Curious Minds
Leonardo English

More by Oxford University

Strachey Lectures
Oxford University
Anthropology
Oxford University
Global Economic Governance: Globalisation and the Financial Crisis
Oxford University
Department of Sociology Podcasts
Oxford University
Literature, Art and Oxford
Oxford University
Cancer
Oxford University